Innovacell (TSE:504A) Other Current Receivables: 円401.22 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:504A Innovacell Inc TSE:504A
10 GF Score
Price 円583.00
View Full Analysis

What is Innovacell Other Current Receivables?

Innovacell TSE:504A +7.56% 10 Other Current Receivables is 円401.22 Mil as of Jun. 2026. GuruFocus rates TSE:504A with a GF Score™ of 10/100.

Innovacell's Other Current Receivables for the quarter that ended in Jun. 2026 was 円401.22 Mil.

Innovacell's quarterly Other Current Receivables increased from Dec. 2025 (円260.16 Mil) to Mar. 2026 (円332.56 Mil) and increased from Mar. 2026 (円332.56 Mil) to Jun. 2026 (円401.22 Mil).

Innovacell's annual Other Current Receivables increased from Dec. 2023 (円223.35 Mil) to Dec. 2024 (円243.00 Mil) and increased from Dec. 2024 (円243.00 Mil) to Dec. 2025 (円260.16 Mil).


Innovacell Other Current Receivables Related Terms


Innovacell Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Innovacell's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovacell Other Current Receivables Chart

Innovacell Annual Data
Trend Dec23 Dec24 Dec25
Other Current Receivables
223.35 243.00 260.16

Innovacell Quarterly Data
Dec23 Dec24 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial 243.00 376.18 260.16 332.56 401.22
TSE:504A
10GF Score
Innovacell Inc TSE:504A
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovacell Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of 円401.22 Mil mean?
Innovacell (TSE:504A) has a Other Current Receivables of 円401.22 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Innovacell and its competitors.
Is Innovacell's Other Current Receivables too high?
Innovacell's current Other Current Receivables is 円401.22 Mil. Overall, Innovacell has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Innovacell's Other Current Receivables compare to VRTX and REGN?
Innovacell's Other Current Receivables of 円401.22 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Innovacell and its competitors. Innovacell's current Other Current Receivables is 円401.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovacell stock overvalued right now?
Innovacell (TSE:504A) has a current Other Current Receivables of 円401.22 Mil. The current Other Current Receivables is 円401.22 Mil. Innovacell's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Innovacell (TSE:504A), the current Other Current Receivables is 円401.22 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovacell Business Description

Address 3-5-11 Kamiosaki, Meguro Villa Garden, 5th floor, Shinagawa-ku, Tokyo, JPN, 141-0021
Innovacell Inc is engaged in the development, manufacturing, and sale of regenerative medicine products for the treatment of conditions including fecal and urinary incontinence. Its activities include researching potential therapeutic candidates, developing formulations, and commercializing products in the markets. The company is working on the development and commercialization of the following three cell therapy pipelines targeting incontinence (fecal and urinary incontinence): ICEF15, ICEF16, and ICES13.
10GF Score

Get the complete analysis for TSE:504A

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円583.00
Price